Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 37, Issue 1, Pages 157-166Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/eji.200636428
Keywords
CD8 T cell; memory; OX40
Categories
Funding
- NATIONAL CANCER INSTITUTE [R01CA102577] Funding Source: NIH RePORTER
- NCI NIH HHS [R01-CA102577-04] Funding Source: Medline
Ask authors/readers for more resources
There is growing evidence that engagement of OX40 (CD134), a member of the TNF shown that CD8(+) T cells express OX40 following activation, but the response of antigen-specific CD8(+) T cells to OX40 stimulation has not been fully characterized. We utilized an antigen-specific transgenic CD8(+) T cell model (OT-1) to determine if OX40 engagement can boost the generation of antigen-specific CD8(+) T cell memory. Our results demonstrate that enhanced OX40 costimulation, via an agonist anti-OX40 antibody, increases CD25 and phospho-Akt expression on the antigen-specific CD8(+) T cells and significantly increases the generation of long-lived antigen-specific CD8(+) memory T cells. The increased numbers of memory CD8(+) T cells generated via anti-OX40 treatment still required the presence of CD4(+) T cells for their long-term maintenance in vivo. In addition, anti-OX40 costimulation greatly enhanced antigen-specific CD8(+) T cell recall responses. These data show that OX40 engagement in vivo increases the number of antigen-specific CD8(+) memory T cells surviving after antigen challenge and has implications for the development of more potent vaccines against pathogens and cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available